Health Care/Hospital

LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital

TOKYO, Aug. 29, 2024 /PRNewswire/ -- LOTTE Holdings Co., Ltd. ("LOTTE Holdings") is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital ("CVC") dedicated to investing in biopharmaceuticals and next-generation modalities.

2024-08-29 10:00 1988

Necessary Care or Abuse? Unpacking the Reason Behind Overprescription

SINGAPORE, Aug. 29, 2024 /PRNewswire/ -- Have you ever wondered if the ten prescriptions your doctor gave you for a cold are truly necessary? Or is there a more complex issue of abuse happening behind the scenes? Today's Case: Overcharging a 7-Year-Old Somsak (an alias name), a 7-year-old boy fr...

2024-08-29 08:30 2454

Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024

SAN FRANCISCO and SUZHOU, China, Aug. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2024-08-29 08:00 1836

USANA Achieves HR Asia's "Best Companies to Work For" Title for Three Consecutive Years

MANILA, Philippines, Aug. 29, 2024 /PRNewswire/ -- USANA Philippines has once again been honored with the prestigious HR Asia Award for being one of the Best Companies to Work For inthe Philippines. This marks the third consecutive year the company has received this esteemed recognition, undersco...

2024-08-29 07:37 1398

iHerb Marks its Commitment to Global Health and Wellness with 28th Anniversary Sales Event

Month-Long Promotions Commemorate Company's Roots as a Small California Startup to a Thriving Global E-commerce Retailer IRVINE, Calif., Aug. 29, 2024 /PRNewswire/ -- iHerb, one of the world's leading online retailers for vitamins, minerals, supplements and other health and wellness products, is...

2024-08-29 06:57 2324

Odie's Oil Introduces Free Handbook of Toxic Finish Coatings for Finishers & Specifiers

TALLAHASSEE, Fla., Aug. 29, 2024 /PRNewswire/ -- Public Service Announcement Wood finishes, concrete finishes, and other finish coatings are more often than not -laden with toxic chemicals. Coming into physical contact including skin contact, accidental ingestion, or inhalation of these materials...

2024-08-29 05:07 2617

Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization

* Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS, and is also the only study to achieve the primary endpoint while showing a positive trend in OS benefit; HARMONi-A study presented in an oral p...

2024-08-29 04:20 2329

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

SHENZHEN, China, Aug. 28, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO ) ("UTime" or the "Company") has officially announced the signing of a ...

2024-08-28 23:06 2643

Fosun Int'l: Total Revenue for 1H2024 Reaches RMB97.84 Bn, Industrial Operation Profit Amounts to RMB 3.47 Bn

Powered by Core Strengths, Focus on Core Businesses & Reinforce Organic Growth Momentum 2024 Interim Results Highlights: * Total revenue maintained growth, reaching RMB97.84 billion; * Industrial operation profit maintained growth, reaching RMB3.47 billion; * Continued focus on core busines...

2024-08-28 21:51 2774

Jenscare, with innovative TTVR, releases 2024H1 interim results

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 endedJune 30, 2024...

2024-08-28 21:00 2230

Bloomage Showcases Key Bioactive Substances at CPHI and HI Korea

SEOUL, South Korea, Aug. 28, 2024 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substances, showcased its new products releasing inSouth Korea at CPHI and HI Korea 2024, two of the largest exhibitions related to health and functional foods, held betweenAug. 27 t...

2024-08-28 21:00 1601

Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Leverage Metabolomics Data to Better Understand the Molecular Mechanisms of Rheumatoid Arthritis

Partnership seeks to identify rheumatoid arthritis biomarkers to improve understanding of disease risk, progression, and treatment responses MORRISVILLE, N.C. and GLASGOW, Scotland, Aug. 28, 2024 /PRNewswire/ --  Metabolon, Inc., the global leader in providing metabolomics solutions advancing a w...

2024-08-28 20:00 1496

Sasakawa Leprosy Initiative Collaborates with Miss Supranational 2024 for Leprosy Awareness Campaign in South Sulawesi, Indonesia

TOKYO, Aug. 28, 2024 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative (SLI) recently conducted a series of leprosy awareness activities in South Sulawesi,Indonesia, in partnership with Miss Supranational 2024 crown holder, Miss Harashta Haifa Zahra. The activities were carried out i...

2024-08-28 19:00 1726

Innovent Announces 2024 Interim Results and Business Updates

Strong commercial performance and significant pipeline milestones support sustained growth and innovation SAN FRANSISCO and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and com...

2024-08-28 18:42 2903

Tigermed Reports 2024 Interim Results

HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its int...

2024-08-28 18:26 1867

Fosun Pharma Announces 2024 Interim Results

Breakthroughs for Innovative Products Going Overseas with Global Operation Capabilities Continuing to Strengthen SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- On August 27, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH; 02196.HK), announced its o...

2024-08-28 18:10 1875

Huawei Announces All-New HUAWEI TruSense System that Will Power Upcoming Wearables

DONGGUAN, China, Aug. 28, 2024 /PRNewswire/ -- On August 28, HUAWEI TruSense System was unveiled to the world. This innovation-driven system marks another milestone in bringing accurate, science-based health & fitness tech to users.

2024-08-28 17:56 1785

Harbour BioMed Announces 2024 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology an...

2024-08-28 17:44 1835

Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization

* "Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" * "While maintaining the current process for emergency use authorization for mild-to-moderate COVID-19 patients, Hyundai Bioscience will expedite Phase 3 clinical tr...

2024-08-28 17:29 1205

"Application and Awareness of Thermal Paper in Hong Kong" - Laboratory Testing and Survey Findings

80% of receipts contain toxins, 70% exceed safety standards; Using receipts for expense claims, e-receipts are eco-friendly and cost-saving HONG KONG , Aug. 28, 2024 /PRNewswire/ -- In today's fast-paced and highly consumer-driven society, thermal paper has become an indispensable part of our da...

2024-08-28 17:25 1452
1 ... 42434445464748 ... 847

Week's Top Stories